(Q44872972)

7 December 2017

title

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells (English)

1 reference

B-cell chronic lymphocytic leukemia

7 December 2017

1 reference

1 reference

1 reference

Lucas DM

1

1 reference

7 December 2017

Davis ME

2

1 reference

7 December 2017

Parthun MR

3

1 reference

7 December 2017

Mone AP

4

1 reference

7 December 2017

Kitada S

5

1 reference

7 December 2017

Cunningham KD

6

1 reference

7 December 2017

Flax EL

7

1 reference

7 December 2017

Wickham J

8

1 reference

7 December 2017

Reed JC

9

1 reference

7 December 2017

Byrd JC

10

1 reference

7 December 2017

Grever MR

11

1 reference

7 December 2017

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

18

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1207-1214

1 reference

7 December 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Review: chromatin structural features and targets that regulate transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Modulation of Akt kinase activity by binding to Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

BCL-2 Selectively Interacts with the BID-induced Open Conformer of BAK, Inhibiting BAK Auto-oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Humanization and characterization of the anti-HLA-DR antibody 1D10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

A positive role for histone acetylation in transcription factor access to nucleosomal DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

inferred from DOI database lookup

7 January 2021

based on heuristic

Blood donor leukocyte reduction filters as a source of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403388

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403388

1 reference

7 December 2017

1 reference